Use of sirolimus rescue therapy in pediatric liver transplant recipients with tacrolimus-based immunosuppression.

被引:0
|
作者
Kato, T
Pinna, AD
Weppler, D
Gonzalez, ML
Mittal, N
Khan, FA
Nery, JR
Tzakis, AG
机构
[1] Univ Miami, Sch Med, Div Transplantat, Miami, FL USA
[2] Univ Miami, Sch Med, Div Pediat Gastroenterol, Miami, FL USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
200
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 50 条
  • [31] Bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression.
    Singh, N
    Gayowski, T
    Wagener, MM
    Marino, IR
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 327 - 327
  • [32] Efficacy and safety of basiliximab with a Tacrolimus-based regimen in liver transplant recipients
    Marino, IR
    Doria, C
    Scott, VL
    Foglieni, CS
    Lauro, A
    Piazza, T
    Cintorino, D
    Gruttadauria, S
    TRANSPLANTATION, 2004, 78 (06) : 886 - 891
  • [33] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Mathew, James M.
    Miller, Joshua
    Heinrichs, Jessica
    Huang, Xumei
    Abecassis, Michael M.
    HEPATOLOGY, 2016, 64 : 1A - 1A
  • [34] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Burrell, Bryna E.
    Kanaparthi, Sai
    Turka, Laurence A.
    Kurian, Sunil
    Sanchez-Fueyo, Alberto
    Lozano, Juan J.
    Demetris, Anthony
    Lesniak, Andrew
    Kirk, Allan D.
    Stempora, Linda
    Yang, Guang-Yu
    Mathew, James M.
    HEPATOLOGY, 2020, 72 (02) : 569 - 583
  • [35] Use of Basiliximab Induction in Low-Immunological Risk Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression
    Gavela Martinez, E.
    Avila Bernabeu, A. I.
    Sancho Calabuig, A.
    Beltran Catalan, S.
    Escudero Quesada, V.
    Pallardo Mateu, L. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2337 - 2338
  • [36] Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression
    Paolillo, JA
    Boyle, GJ
    Law, YM
    Miller, SA
    Lawrence, K
    Wagner, K
    Pigula, FA
    Griffith, BP
    Webber, SA
    TRANSPLANTATION, 2001, 71 (02) : 252 - 256
  • [37] Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation
    Andrews, WS
    Sommerauer, J
    Conlin, C
    Moore, P
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 897 - 898
  • [38] Influence of Induction Therapy Using Basiliximab With Delayed Tacrolimus Administration in Heart Transplant Recipients - Comparison With Standard Tacrolimus-Based Triple Immunosuppression -
    Watanabe, Takuya
    Yanase, Masanobu
    Seguchi, Osamu
    Fujita, Tomoyuki
    Hamasaki, Toshimitsu
    Nakajima, Seiko
    Kuroda, Kensuke
    Kumai, Yuto
    Toda, Koichi
    Iwasaki, Keiichiro
    Kimura, Yuki
    Mochizuki, Hiroki
    Anegawa, Eiji
    Sujino, Yasumori
    Yagi, Nobuichiro
    Yoshitake, Koichi
    Wada, Kyoichi
    Matsuda, Sachi
    Takenaka, Hiromi
    Ikura, Megumi
    Nakagita, Kazuki
    Yajima, Shin
    Matsumoto, Yorihiko
    Tadokoro, Naoki
    Kakuta, Takashi
    Fukushima, Satsuki
    Ishibashi-Ueda, Hatsue
    Kobayashi, Junjiro
    Fukushima, Norihide
    CIRCULATION JOURNAL, 2020, 84 (12) : 2212 - 2223
  • [39] Incidence of Cytomegalovirus Infection Among Liver Transplant Recipients Maintained on a Cyclosporine vs. Tacrolimus-Based Immunosuppression Regimen
    Burrelli, C.
    Bradley, M.
    Pouch, S.
    Elkhammas, E.
    Winters, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 505 - 506
  • [40] Pediatric renal transplantation under tacrolimus-based immunosuppression
    Shapiro, R
    Scantlebury, VP
    Jordan, ML
    Vivas, C
    Ellis, D
    Lombardozzi-Lane, S
    Gilboa, N
    Gritsch, HA
    Irish, W
    McCauley, J
    Fung, JJ
    Hakala, TR
    Simmons, RL
    Starzl, TE
    TRANSPLANTATION, 1999, 67 (02) : 299 - 303